, Tracking Stock Market Picks
Enter Symbol:
Ace (ACE) [hlAlert]

Neutral ACE
up 78.96 %

Ace (ACE) downgraded to Neutral by Citigroup

Posted on: Wednesday,  Feb 12, 2014  8:25 AM ET by Citigroup

Citigroup rated Neutral Ace (NYSE: ACE) on 02/12/2014. Previously Citigroup rated Buy Ace (NYSE: ACE) on 04/28/2010., when the
stock price was $53.48. Since then, Ace has gained 78.96% as of 02/12/2014's recent price of $95.71.
If you would have followed the previous Citigroup's recommendation on ACE, you would have gained 78.96% of your investment in 1386 days.

Alcon, Inc. is the world's leading eye care company. Alcon, which has been dedicated to the ophthalmic industry for sixty years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon's majority shareholder is Nestle, S.A., the world's largest food company. All trademarks noted in this release are the property of Alcon, Inc., with the exception of Ciprodex, which is a registered trademark of Bayer AG and licensed to Alcon, Inc. by Bayer Healthcare AG. Moxifloxacin is licensed to Alcon, Inc. by Bayer Healthcare AG.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/12/2014 8:25 AM Hold
as of 10/17/2014
1 Week   
1 Month   
3 Months   
1 YTD down  -7.55 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/28/2010 8:25 AM Buy
53.48 64.00
3/9/2010 8:25 AM Hold
7/17/2008 8:25 AM Buy
48.44 63.00
7/9/2008 8:25 AM Hold
54.01 58.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy